Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Clearside Biomedical Inc

CLSD
Current price
1.49 USD +0.16 USD (+12.03%)
Last closed 1.33 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 99 392 368 USD
Yield for 12 month +36.70 %
1Y
3Y
5Y
10Y
15Y
CLSD
21.11.2021 - 28.11.2021

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Address: 900 North Point Parkway, Alpharetta, GA, United States, 30005

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.33 USD

P/E ratio

Dividend Yield

Current Year

+8 226 000 USD

Last Year

+1 327 000 USD

Current Quarter

+230 000 USD

Last Quarter

+6 345 000 USD

Current Year

+7 804 000 USD

Last Year

+1 123 000 USD

Current Quarter

+202 000 USD

Last Quarter

+6 325 000 USD

Key Figures CLSD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -25 379 250 USD
Operating Margin TTM -3569.13 %
PE Ratio
Return On Assets TTM -37.5 %
PEG Ratio
Return On Equity TTM -1310.02 %
Wall Street Target Price 5.33 USD
Revenue TTM 8 452 000 USD
Book Value -0.31 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 5650 %
Dividend Yield
Gross Profit TTM 1 123 000 USD
Earnings per share -0.55 USD
Diluted Eps TTM -0.55 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CLSD

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CLSD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CLSD

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 7.9619
Price Sales TTM 11.3544
Enterprise Value EBITDA -2.8404
Price Book MRQ 3.927

Financials CLSD

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CLSD

For 52 weeks

0.65 USD 2.12 USD
50 Day MA 1.42 USD
Shares Short Prior Month 265 276
200 Day MA 1.16 USD
Short Ratio 1.28
Shares Short 338 681
Short Percent 0.48 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

425.34 USD Microsoft Corporation +5.34 (+1.27%)
Detailed analytics

ETF funds


S

SX7EEX

14.76 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.11 (+0.7%)
Detailed analytics

Metals


Gold

2415.8 USD Gold +1.74 (+0.07%)
Detailed analytics